Items where Author is "Labopin, M."

Article

Vrhovac, R. and Labopin, M. and Ciceri, F. and Finke, J. and Holler, E. and Tischer, J. and Lioure, B. and Gribben, J. and Kanz, L. and Blaise, D. and Dreger, P. and Held, G. and Arnold, R. and Nagler, A. and Mohty, M. (2016) Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes. BONE MARROW TRANSPLANTATION, 51 (2). pp. 186-193. ISSN 0268-3369, 1476-5365

von Bahr, L. and Blennow, O. and Alm, J. and Bjorklund, A. and Malmberg, K-J and Mougiakakos, D. and Le Blanc, A. and Oefner, P. J. and Labopin, M. and Ljungman, P. and Le Blanc, K. (2015) Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation. BONE MARROW TRANSPLANTATION, 50 (9). pp. 1217-1223. ISSN 0268-3369, 1476-5365

Conference or Workshop Item

Kirgizov, K. and Greco, R. and Badoglio, M. and Labopin, M. and Saccardi, R. and Rovira, M. and Farge, D. and Schaap, N. and Moore, J. and Polushin, A. and Finke, J. and Alexander, T. and Burman, J. and del Papa, N. and Greenfield, D. M. and Kazmi, M. and Rovo, A. and Schoemans, H. and Sharrack, B. and Tichelli, A. and Bader, P. and Corbacioglu, Selim and Peric, Z. and Basak, G. W. and Snowden, J. A. (2022) O025 Late complications after autologous HSCT for autoimmune diseases: a retrospective study from the EBMT autoimmune. In: 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), March 19-23, 2022, Czech Republik.

Other

Brissot, E. and Labopin, M. and Stelljes, M. and Ehninger, G. and Schwerdtfeger, R. and Zander, A. R. and Mielke, S. and Ganser, A. and Finke, J. and Schufer-Eckart, K. and Bunjes, D. and Kroeger, N. and Schmid, C. and Bethge, W. A. and Kolb, H. J. and Blau, I. W. and Vitek, A. and Bochtler, T. and Meyer, R. G. and Holler, E. and Esteve, J. and Nagler, A. and Mohty, M. (2015) UNRELATED DONOR (UD) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA (AML): REPORT OF 381 PATIENTS FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT. FERRATA STORTI FOUNDATION, PAVIA.

Vrhovac, R. and Labopin, M. and Ciceri, F. and Finke, J. and Holler, E. and Tischer, J. and Lioure, B. and Gribben, J. and Kanz, L. and Blaise, D. and Dreger, P. and Nagler, A. and Held, G. and Arnold, R. and Mohty, M. (2014) SECOND RIC ALLOGENEIC TRANSPLANT AS A RESCUE STRATEGY FOR ACUTE LEUKAEMIA PATIENTS WHO RELAPSE AFTER AN INITIAL RIC ALLOGENEIC TRANSPLANTATION: ANALYSIS OF RISK FACTORS AND TREATMENT OUTCOMES. NATURE PUBLISHING GROUP, LONDON.